page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Insulin, Regular

Category:

  • Miscellaneous

Description:

  • Antidiabetic agent

Indications:

  • Diabetes mellitus

  • Diabetic ketoacidosis

  • Hyperkalemia

  • Nutritional supplementation

Contraindications:

  • Hypoglycemia, porcine hypersensitivity (if from pork)

Precautions:

  • Pregnancy category B

  • Hypoglycemia related to dose

  • Renal impairment/failure, hepatic disease

Adverse Reactions (Side Effects):

  • anaphylactoid reactions, hyperinulinism, hypoglycemia, hypokalemia

  • reaction at injection site, insulin resistance, lipodystrophy, nausea, vomiting

  • pruritus, sinus tachycardia, urticaria

 

 

Dosage:

Administered subcutaneously, intramuscularly, and intravenously

  • Diabetes mellitus type I or diabetes type II inadequately managed by diet and oral hypoglycemics: 

    • Adult and child: 

      • SC range 0.1-2.5 units/kg/day; 

      • most patients require 0.5-1.2 units/kg/day.

  • Diabetic ketoacidosis: 

    • Adult: Initially, 0.1 unit/kg/hr continuous IV INF in addition to adequate fluid therapy (usually 0.9% NaCl at 1 L/hour for 2-3 hours, then 0.45% NaCl).  

    • When blood glucose reaches 250 mg/dl, fluid therapy should be changed to 5% dextrose in 0.45% NaCl, while IV INF of insulin is continued at roughly half the initial rate until acidosis is also corrected.

  • Child: 

    • Initially, 0.1 unit/kg IV BOLUS, followed by 0.1 unit/kg/hour (range 0.05-0.2 units/kg/hour) continuous IV INF until blood glucose reaches 250 mg/dl, at which time IV dextrose may be added while IV INF of insulin is continued until acidosis is also corrected.

  • Nutiritional supplement in neonates to optimize caloric intake while on parenteral nutrition:  

    • 0.01-0.1 units/kg/hour via continuous IV INF. (start at lower end of dosage range)

  • Hyperkalemia: 

    • Adult: 5-10 units IV in 50ml D50W over 5 minutes

Subcutaneous Dosing:

  • Individualize dosage based on careful monitoring of blood glucose and other clinical parameters.

  • Administer 30 minutes prior to a meal

  • Inject into upper thighs, upper arms, buttocks, or abdomen.  Inject over 2-4 seconds.

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site